MYRICX PHARMA LIMITED
Research and experimental development on biotechnology
MYRICX PHARMA LIMITED
Research and experimental development on biotechnology
Contact & Details
Contact
Registered Address
125 Wood Street London EC2V 7AW United Kingdom
Full company profile for MYRICX PHARMA LIMITED (12082645), an active life sciences and medical technology company based in London, United Kingdom. Incorporated 3 Jul 2019. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.
Business Summary
This company specializes in providing innovative solutions and services across multiple sectors. Sign up to viewReports
Credit Report
In-depth credit score, financial analysis, risk assessment and company intelligence.
Financials
Financials
Net Assets, Total Assets & Total Liabilities (2020–2025)
Cash in Bank
£38.59M
Net Assets
£40.56M
Total Liabilities
£3.19M
Turnover
N/A
Employees
13
Debt Ratio
7%
Financial History
Revenue, profit, EBITDA and key financial figures
2025 31 Jul Year End | 2023 31 Jul Year End | |
|---|---|---|
| P&L | ||
| Revenue | ||
| Gross Profit | ||
| Operating Profit | ||
| Net Profit | ||
| EBITDA | ||
| Assets | ||
| Cash | ||
| Total Assets | ||
| Liabilities | ||
| Total Liabilities | ||
| Key Metrics | ||
| Employees | ||
Funding
Fundraising & Grants
Investors (8)
| Investor Name | Investor Since | Participating Rounds |
|---|---|---|
| Investor 6 | Nov 2020 | Series A, Seed |
| Investor 8 | Nov 2020 | Seed |
| Investor 1 | Jul 2024 | Series A |
See all 8 investors
Sign up to view complete investor information
Officers
Officers
| Status | |||||
|---|---|---|---|---|---|
| Christopher John Martin | Director | British | Switzerland | 10 Nov 2023 | Active |
| Robin Arthur Ellis Carr | Director | British | United Kingdom | 11 Oct 2022 | Active |
See all 15 officers
Sign up to view the full officer history
Persons with Significant Control
Persons with Significant Control (0)
Professor Edward William Tate
Ceased 30 Oct 2019
Group Structure
Group Structure
No group structure identified
Charges
Charges
No charges registered
Properties
Properties
No related properties
Documents
Company Filings
| Date | Category | Description | Document |
|---|---|---|---|
| 3 Mar 2026 | Capital | Allotment of shares (GBP 899.4688) on 23 Feb 2026 | |
| 19 Feb 2026 | Capital | Allotment of shares (GBP 583.46882) on 14 Feb 2026 | |
| 23 Jan 2026 | Capital | Allotment of shares (GBP 577.49706) on 21 Jan 2026 | |
| 4 Dec 2025 | Accounts | Annual accounts made up to 31 Jul 2025 | |
| 11 Nov 2025 | Officers | Appointment of Dr Jayson Punwani as director on 10 Nov 2025 |
Allotment of shares (GBP 899.4688) on 23 Feb 2026
Allotment of shares (GBP 583.46882) on 14 Feb 2026
Allotment of shares (GBP 577.49706) on 21 Jan 2026
Annual accounts made up to 31 Jul 2025
Appointment of Dr Jayson Punwani as director on 10 Nov 2025
Recent Activity
Latest Activity
Allotment of shares (GBP 899.4688) on 23 Feb 2026
3 months ago on 3 Mar 2026
Allotment of shares (GBP 583.46882) on 14 Feb 2026
3 months ago on 19 Feb 2026
Allotment of shares (GBP 577.49706) on 21 Jan 2026
4 months ago on 23 Jan 2026
Annual accounts made up to 31 Jul 2025
6 months ago on 4 Dec 2025
Appointment of Dr Jayson Punwani as director on 10 Nov 2025
6 months ago on 11 Nov 2025